Expert Review of Gastroenterology & Hepatology

Papers
(The TQCC of Expert Review of Gastroenterology & Hepatology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Multidetector computed tomography angiography in non-variceal upper gastrointestinal bleeding: when, why and how?42
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors39
Managing pain in irritable bowel syndrome: current perspectives and best practice32
Leucine-rich alpha-2 glycoprotein as a blood biomarker in inflammatory bowel disease: clinical implications and future perspectives31
Impact of yoga therapy in intestinal disorders29
Addressing current limitations of colonoscopy for colorectal cancer screening28
Targeting liver metabolism: a pathway to cure hepatitis B virus?27
Small bowel transplant – novel indications and recent progress27
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions27
Therapeutic drug monitoring in inflammatory bowel disease: recent developments26
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences25
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis25
Recent advances in treating constipation in children24
Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms22
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?22
Gender-related differences in celiac disease presentation and follow-up in adult patients22
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)21
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease21
Elucidating the role of extracellular vesicles in liver injury induced by HIV21
A narrative review on the diagnosis and management of constipation in infants20
The assessment of impaired liver function and prognosis in hepatocellular carcinoma19
High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites19
Irritable bowel syndrome – controversies in diagnosis and management19
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management19
The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review18
Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities18
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice18
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction18
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis18
Managing bile acid diarrhea: aspects of contention17
Investigating the correlation between COVID-19 and the progression of chronic liver disease17
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract17
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice17
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment17
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?16
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont15
Small bowel imaging in inflammatory bowel disease: updates for 202315
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis15
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis15
IBD in women of reproductive age: where do novel therapies fit in?14
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States14
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery13
Evaluating the role of endoscopic ultrasound in pancreatitis13
Psychological distress in inflammatory bowel disease13
The impact of a multidisciplinary team evaluation on the diagnosis and management of acute and chronic pancreatitis in a tertiary referral center13
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective13
Updates on intestinal failure management13
Techniques and outcomes review of the endoscopic management of gastrointestinal bleeding12
Noninvasive diagnosis of clinically significant portal hypertension: current evidence and future directions12
Contemporary epidemiology of metabolic dysfunction-associated steatotic liver disease12
Carcinoid syndrome mimicking irritable bowel syndrome: don’t fall into the trap12
EUS-guided choledochoduodenostomy (EUS-CDS) with lumen-apposing metal stents (LAMS): a comprehensive technical review12
Managing pediatric Crohn’s disease: recent insights12
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives11
Diagnosing eosinophilic esophagitis in pediatric patients11
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review11
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays11
Gastroesophageal reflux disease in preterm infants: unmet needs11
Managing complications of chronic pancreatitis: a guide for the gastroenterologist11
Clinical management of inflammatory bowel disease from preconception to postpartum10
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults10
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art10
Safety and use of IBD therapies during pregnancy and lactation10
Optimizing nutritional care across the continuum from intensive care to recovery: an expert opinion review10
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis10
Reply to letter to the Editor: Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis10
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis10
Highlighting novel targets in immunotherapy for liver cancer10
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study10
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma10
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation10
Management of disease-related abdominal abscesses in Crohn’s disease10
Towards a better diagnosis of gastro esophageal reflux disease10
Rome V criteria for pediatric disorders of gut – brain interaction: key updates and clinical implications9
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece9
Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease9
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview9
Characterizing Crohn’s disease phenotypes through pan-enteric capsule endoscopy9
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights9
PSC patient with jaundice – should we ERCP?9
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges9
Introducing the “Guideline Comparison” article type9
Endoscopic follow-up in patients with first-degree relatives for gastric cancer: a real-world observational study9
The TL1A inhibitors in IBD: what’s in the pot?9
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis8
Nutritional aspects of inflammatory bowel disease8
Medical management of acute severe ulcerative colitis in the hospitalized patient8
Acute severe ulcerative colitis: defining the precise moment for colectomy8
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn’s disease8
Prioritization in inflammatory bowel disease therapy8
2023 update on the clinical management of gastroparesis8
Induction and maintenance of healing in erosive esophagitis in the United States8
Microbial ecology and hepatocellular carcinoma: should a subset be viewed as a microbiome-conditioned malignancy?8
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity8
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect8
Clinical role of anti-PD-1 immunotherapies in esophageal cancer8
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease8
Radiation safety and dose management in fluoroscopy-guided gastrointestinal procedures: current evidence and future perspectives8
Systematic mapping of worldwide research on intra-pancreatic fat deposition8
Histamine-producing bacteria and their role in gastrointestinal disorders8
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis8
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review8
3.749330997467